1. Home
  2. ICHR vs TMDX Comparison

ICHR vs TMDX Comparison

Compare ICHR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$85.73

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$73.64

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
TMDX
Founded
1999
1998
Country
United States
United States
Employees
2448
N/A
Industry
Semiconductors
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
ICHR
TMDX
Price
$85.73
$73.64
Analyst Decision
Strong Buy
Buy
Analyst Count
6
9
Target Price
$49.50
$148.22
AVG Volume (30 Days)
1.2M
969.8K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
382.18
EPS
N/A
0.20
Revenue
$947,652,000.00
$605,494,000.00
Revenue This Year
$20.51
$24.25
Revenue Next Year
$17.08
$18.75
P/E Ratio
N/A
$355.65
Revenue Growth
11.61
37.13
52 Week Low
$13.15
$60.11
52 Week High
$113.58
$156.00

Technical Indicators

Market Signals
Indicator
ICHR
TMDX
Relative Strength Index (RSI) 47.17 47.33
Support Level $79.47 $64.87
Resistance Level $113.58 $79.60
Average True Range (ATR) 7.55 3.13
MACD -1.18 0.02
Stochastic Oscillator 38.18 34.57

Price Performance

Historical Comparison
ICHR
TMDX

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: